Omnicell, Inc. (OMCL)
| Market Cap | 4.84B |
| Revenue (ttm) | 1.26B |
| Net Income (ttm) | 60.58M |
| Shares Out | 44.29M |
| EPS (ttm) | 1.20 |
| PE Ratio | 90.98 |
| Forward PE | 29.50 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 575,451 |
| Open | 107.80 |
| Previous Close | 107.33 |
| Day's Range | 107.50 - 112.88 |
| 52-Week Range | 103.62 - 187.29 |
| Beta | 1.04 |
| Analysts | Buy |
| Price Target | 160.78 (+47.3%) |
| Earnings Date | Aug 4, 2022 |
About OMCL
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software... [Read more...]
Financial Performance
In 2021, Omnicell's revenue was $1.13 billion, an increase of 26.88% compared to the previous year's $892.21 million. Earnings were $77.85 million, an increase of 141.81%.
Financial StatementsAnalyst Forecast
According to 15 analysts, the average rating for OMCL stock is "Buy." The 12-month stock price forecast is 160.78, which is an increase of 47.26% from the latest price.
News
Omnicell (OMCL) Q2 Earnings Miss Estimates, Gross Margin Down
Robust sales contribution from product and services segments drove Omnicell's (OMCL) Q2 top line.
MDRX vs. OMCL: Which Stock Should Value Investors Buy Now?
MDRX vs. OMCL: Which Stock Is the Better Value Option?
Omnicell (OMCL) Misses Q2 Earnings and Revenue Estimates
Omnicell (OMCL) delivered earnings and revenue surprises of -1.18% and 2.37%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Omnicell Announces Financial Results for Second Quarter 2022
SANTA CLARA, Calif.--(BUSINESS WIRE)--Omnicell Announces Financial Results for Second Quarter 2022
Analysts Estimate Omnicell (OMCL) to Report a Decline in Earnings: What to Look Out for
Omnicell (OMCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Omnicell to Release Second Quarter 2022 Financial Results on August 4, 2022
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell to Release Second Quarter 2022 Financial Results on August 4, 2022
Omnicell (OMCL) Up 10% Since Q1 Earnings: What's Driving It?
Investors are optimistic about Omnicell's (OMCL) strategic partnerships and continued innovations for the Autonomous Pharmacy.
ENOV vs. OMCL: Which Stock Should Value Investors Buy Now?
ENOV vs. OMCL: Which Stock Is the Better Value Option?
3 Medical Info System Stocks Braving Industry Headwinds
Medical Info Systems stocks like Omnicell, Inc. (OMCL), Axonics, Inc. (AXNX) and Outset Medical, Inc. (OM) are expected to gain despite pandemic-led disruptions.
CPSI vs. OMCL: Which Stock Is the Better Value Option?
CPSI vs. OMCL: Which Stock Is the Better Value Option?
Here's Why Investors Should Retain Omnicell (OMCL) Stock Now
Investors are optimistic about Omnicell's (OMCL) better-than-expected results and new launches.
CPSI vs. OMCL: Which Stock Should Value Investors Buy Now?
CPSI vs. OMCL: Which Stock Is the Better Value Option?
Omnicell (OMCL) Q1 Earnings Top Estimates, Margins Decline
Robust sales performance across Omnicell's (OMCL) operating segments has contributed to the first-quarter top line.
Omnicell (OMCL) Q1 Earnings and Revenues Beat Estimates
Omnicell (OMCL) delivered earnings and revenue surprises of 16.90% and 0.70%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Omnicell Announces Financial Results for First Quarter 2022
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell Announces Financial Results for First Quarter 2022
CPSI or OMCL: Which Is the Better Value Stock Right Now?
CPSI vs. OMCL: Which Stock Is the Better Value Option?
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
These companies have a history of creating shareholder value -- and still have plenty of room for growth.
Omnicell to Release First Quarter 2022 Financial Results on April 28, 2022
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell to Release First Quarter 2022 Financial Results on April 28, 2022
Omnicell (OMCL) Progresses With Intelligent Infrastructure Tools
Omnicell's (OMCL) IVX Station robotic compounding technology apparently supports three times the throughput speed of the current IV robotic technology.
Omnicell Unveils Innovative IVX Station Robotic Compounding Technology in Winter 2022 Release
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell, Inc. (Nasdaq: OMCL), a leading provider of medication management and adherence tools for health systems and pharmacies, today announced the launch of IV...
Omnicell (OMCL) Down 5.6% Since Last Earnings Report: Can It Rebound?
Omnicell (OMCL) reported earnings 30 days ago. What's next for the stock?
Omnicell Announces Changes to Its Board of Directors
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell Announces Changes to its Board of Directors
CHNG vs. OMCL: Which Stock Is the Better Value Option?
CHNG vs. OMCL: Which Stock Is the Better Value Option?
Omnicell (OMCL) Q4 Earnings Miss Estimates, Revenues Beat
Robust performance by the Product and Service segments is driving Omnicell's (OMCL) fourth-quarter top line.
Omnicell (OMCL) Lags Q4 Earnings Estimates
Omnicell (OMCL) delivered earnings and revenue surprises of -3.16% and 0.30%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?